Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

Christina Canavati; Ahmad Siam; Sapir Labes; Nirit Trabelsi; Eshcar Regev; Elchanan Parnasa; Barhoum Barhoum; Nur Magadle; Ofer Perzon; Maya Braun; Hagar Mor-Shaked; Ora Schueler-Furman; Yuval Tabach; Dror Mevorach

doi:https://doi.org/10.1161/circulationaha.123.064884

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

Christina Canavati, Ahmad Siam, Sapir Labes, Nirit Trabelsi, Eshcar Regev, Elchanan Parnasa, Barhoum Barhoum, Nur Magadle, Ofer Perzon, Maya Braun, Hagar Mor-Shaked, Ora Schueler-Furman, Yuval Tabach, Dror Mevorach

The Hebrew University of Jerusalem

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	270-273
Number of pages	4
Journal	Circulation
Volume	149
Issue number	3
DOIs	https://doi.org/10.1161/circulationaha.123.064884
State	Published - 16 Jan 2024

All Science Journal Classification (ASJC) codes

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

https://doi.org/10.1161/circulationaha.123.064884

Cite this

Canavati, C., Siam, A., Labes, S., Trabelsi, N., Regev, E., Parnasa, E., Barhoum, B., Magadle, N., Perzon, O., Braun, M., Mor-Shaked, H., Schueler-Furman, O., Tabach, Y., & Mevorach, D. (2024). Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19). Circulation, 149(3), 270-273. https://doi.org/10.1161/circulationaha.123.064884

@article{25f66506668a46b398d0d03f6658035c,

title = "Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)",

author = "Christina Canavati and Ahmad Siam and Sapir Labes and Nirit Trabelsi and Eshcar Regev and Elchanan Parnasa and Barhoum Barhoum and Nur Magadle and Ofer Perzon and Maya Braun and Hagar Mor-Shaked and Ora Schueler-Furman and Yuval Tabach and Dror Mevorach",

year = "2024",

month = jan,

day = "16",

doi = "https://doi.org/10.1161/circulationaha.123.064884",

language = "الإنجليزيّة",

volume = "149",

pages = "270--273",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "3",

}

Canavati, C, Siam, A, Labes, S, Trabelsi, N, Regev, E, Parnasa, E, Barhoum, B, Magadle, N, Perzon, O, Braun, M, Mor-Shaked, H, Schueler-Furman, O , Tabach, Y & Mevorach, D 2024, 'Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)', Circulation, vol. 149, no. 3, pp. 270-273. https://doi.org/10.1161/circulationaha.123.064884

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19). / Canavati, Christina; Siam, Ahmad; Labes, Sapir et al.
In: Circulation, Vol. 149, No. 3, 16.01.2024, p. 270-273.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

AU - Canavati, Christina

AU - Siam, Ahmad

AU - Labes, Sapir

AU - Trabelsi, Nirit

AU - Regev, Eshcar

AU - Parnasa, Elchanan

AU - Barhoum, Barhoum

AU - Magadle, Nur

AU - Perzon, Ofer

AU - Braun, Maya

AU - Mor-Shaked, Hagar

AU - Schueler-Furman, Ora

AU - Tabach, Yuval

AU - Mevorach, Dror

PY - 2024/1/16

Y1 - 2024/1/16

UR - http://www.scopus.com/inward/record.url?scp=85182272674&partnerID=8YFLogxK

U2 - https://doi.org/10.1161/circulationaha.123.064884

DO - https://doi.org/10.1161/circulationaha.123.064884

M3 - رسالة

C2 - 38227712

SN - 0009-7322

VL - 149

SP - 270

EP - 273

JO - Circulation

JF - Circulation

IS - 3

ER -

Pathogenic Variants of Scavenger Receptor CD36 Lead to Decreased Efferocytosis and Predispose to Myocarditis Following Vaccination With Pfizer-BioNTech BNT162b2 Against Coronavirus Infection (COVID-19)

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this